CClinicalTrials.gg
RecruitingNCT05899153Updated Jun 8, 2026

Gait Adaptation and Biofeedback for Cerebral Palsy

An interventional study of Biomotum Spark: Robotic ankle resistance and Audiovisual Biofeedback in Cerebral Palsy, sponsored by University of Washington. Recruiting at 1 site in United States. Open to participants aged 7 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-08.

Sponsored by University of Washington · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Started Nov 2023; still recruiting 2 years 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Non-randomized
Ages
7 Years to 18 Years
Sex
All
01

Study summary

This research aims to evaluate walking function in children with cerebral palsy (CP). The researchers want to understand how children with CP adapt and learn new ways of moving. They have previously found that measuring how a person controls their muscles is important for assessing walking ability and response to interventions. In these studies, they will adjust the treadmill belt speeds and/or provide real-time feedback to evaluate how a child can alter their movement. The feedback will include a wearable exoskeleton that provides resistance to the ankle and audio and visual cues based on sensors that record muscle activity. This research will investigate three goals: first, to measure how children with CP adapt their walking; second, to see if either repeated training or orthopedic surgery can improve adaptation rates; and third, to determine if individual differences in adaptation relate to improvements in walking function after treatment. This research will help develop better treatments to enhance walking capacity and performance for children with CP.

Read the detailed description

Prior research has shown that children with cerebral palsy (CP) use simplified motor control strategies compared to nondisabled (ND) peers, and that these differences in motor control are associated with walking function. While we can quantify motor control during activities like walking, the processes by which a child with CP adapts and learns new movement patterns are poorly understood.

This research will use two paradigms to evaluate adaptation and motor learning in children with CP: walking on a split-belt treadmill and responding to multimodal biofeedback. Walking on a split-belt treadmill, which has two belts set at different speeds to induce asymmetry during walking, has been commonly used to evaluate adaptation in other clinical populations. Responding to multimodal feedback can also be used to evaluate an individual's capacity to adapt their walking pattern. This research will use a real-time multimodal feedback system that targets plantarflexor activity, a key muscle group that is often impaired in CP. Sensorimotor feedback will be provided using a lightweight, body-worn robotic device that provides adaptive ankle resistance and step-by-step audiovisual feedback will be provided based on muscle activity from the plantarflexors using a visual display and audible tone. This research will quantify adaptation rate (e.g., change in soleus activity or step length symmetry) in response to these perturbations, and observe the impact of repeated practice or orthopedic surgery on walking function (e.g., change in walking speed). The specific aims are to:

Aim-1: Quantify adaptation rates in children with CP. We will quantify adaptation rate in response to three perturbation experiments: split-belt treadmill walking, sensorimotor feedback, and audiovisual feedback. The primary hypotheses are that children with CP will exhibit reduced adaptation rates compared to ND peers, and that adaptation rates will be associated with function (Gross Motor Function Measure, GMFM-66).

Aim-2: Determine whether adaptation rates change in response to repeated multimodal feedback training. We will evaluate children with CP who undergo six weeks of multimodal biofeedback training (20-min, 2x/week) or orthopedic surgery. The primary hypothesis is that multimodal feedback training will produce greater changes in adaptation rates than orthopedic surgery.

Aim-3: Determine whether changes in gait after treatment are associated with adaptation rates. Gait analysis will be performed to determine whether baseline adaptation rates are associated with changes in gait after treatment. The primary hypotheses are that baseline adaptation rates will be associated with changes in muscle, joint, and whole-body performance.

02

Conditions studied

  • Cerebral Palsy

Browse trials for

Keywords

  • Gait
  • Rehabilitation
03

In context

Cerebral Palsy

1,853 studies on the registry are indexed under Cerebral Palsy; 435 are open to participants now.

This study's planned enrollment of 36 is close to the median of 33 across 1,368 interventional studies indexed under Cerebral Palsy.

Browse Cerebral Palsy studies →

Lead sponsor

University of Washington is the lead sponsor of 1,397 studies on the registry; 225 are open to participants now.

Of its 154 completed or terminated interventional studies of FDA-regulated products, 132 (86%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

  • Diagnosis of bilateral cerebral palsy that impacts both legs
  • Gross Motor Functional Classification System Level II
  • No surgery or lower-extremity injuries 12 months prior to enrollment
  • No botulinum toxin injections in prior 3 months
  • No prior selective dorsal rhizotomy surgery
  • No history of seizures or cardiac conditions that would preclude walking on a treadmill for 20 minutes
  • No current pain that hinders walking
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
36 participants (estimated)

Study arms

  • Experimental
    Orthopedic Surgery

    Participants who have been scheduled for lower-extremity, multilevel orthopedic surgery will be assessed before and 9-18 months after surgery to evaluate changes in gait and adaptation rates.

    Procedure: Multilevel Orthopedic Surgery

  • Experimental
    Audiovisual + Sensorimotor Biofeedback

    Participants will complete 12 sessions (20 minutes of walking on a treadmill) over a 6-8 week period while receiving both audiovisual and sensorimotor biofeedback. Sensorimotor biofeedback will be provided with an ankle exoskeleton that provides resistance to ankle plantarflexion during the stance phase of gait. The visual feedback will be provided on a screen with a bar showing real-time muscle activity and the audio feedback will be a sound played when they reach the target level of muscle activity from the plantarflexors.

    Device: Biomotum Spark: Robotic ankle resistance · Device: Audiovisual Biofeedback

Interventions

  • DeviceBiomotum Spark: Robotic ankle resistance

    Robotic ankle exoskeleton that provides resistance to ankle plantarflexion.

  • DeviceAudiovisual Biofeedback

    Electromyography recordings from the plantarflexor muscles are used to provide audio feedback via a sound that plays when muscle activity is above target and a visual bar that displays real-time muscle activity.

  • ProcedureMultilevel Orthopedic Surgery

    Musculoskeletal surgeries to address alignment, contracture, and other lower-extremity impairments. This study does not impact surgical decision making but evaluates changes in gait before and after surgery.

06

What researchers measure

Primary outcomes

  1. Change in Soleus Muscle Activity

    Average stance-phase magnitude of soleus muscle activity from electromyography recording measured during gait at 1-month follow-up.

    Time frame: Change from baseline to intervention follow-up, assessed up to 18 months

  2. Change in Peak Ankle Power

    Average peak ankle power evaluated during gait.

    Time frame: Change from baseline to intervention follow-up, assessed up to 18 months

  3. Change in Self-Selected Walking Speed

    Average overground walking speed.

    Time frame: Change from baseline after intervention.

  4. Change in Dynamic Motor Control During Walking (Walk-DMC)

    The total variance account for by one muscle synergy calculated from electromyography recordings during gait.

    Time frame: Change from baseline to intervention follow-up, assessed up to 18 months

  5. Change in Gait Deviation Index (GDI)

    Deviation in gait kinematics compared to nondisabled gait.

    Time frame: Change from baseline to intervention follow-up, assessed up to 18 months

  6. Change in Gross Motor Function Measure - 66 (GMFM-66) Parts D & E

    Assessment tool designed and evaluated to measure changes in gross motor function. Parts D \& E focus on standing, walking, jumping, and running function.

    Time frame: Change from baseline to intervention follow-up, assessed up to 18 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — De-identified participant data from gait analysis and outcome measures will be provided on a public data repository.

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05899153
Lead sponsor
University of Washington
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS), Gillette Children's Specialty Healthcare, Northern Arizona University
Responsible party
Katherine Steele (Professor, Mechanical Engineering, University of Washington) — Principal investigator
First posted
Jun 12, 2023
Start date
Nov 28, 2023
Primary completion
May 1, 2028 (estimated)
Completion
Jan 1, 2029 (estimated)
Last update
Jun 8, 2026

Study contacts

Katherine M Steele, PhD
Contact
kmsteele@uw.edu
206-685-2390
Alyssa Spomer, PhD
Contact
AlyssaMSpomer@gillettechildrens.com
Katherine M Steele, PhD
principal investigator · University of Washington

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion